Glipizide

Dr. McPhee: This is not quite right for Mr. Green. Glipizide is a sulfonylurea that stimulates insulin secretion from the pancreas and thus can be used in type 2 diabetes in cases where first line drugs are not indicated or unavailable. However, it increases the risk of hypoglycaemia and tends to cause weight gain, which are not ideal for a patient who is overweight and has a history of hypertension. Sulfonylureas do not provide the same cardiovascular protection as other drugs, which is a major goal of diabetes management. Think carefully about the broader health context for Mr. Green and try again!

  • Increased secretion of insulin from the pancreas [undo]
  • Amnestic exam [undo]
  • Ξεκινάτε σίτιση με τυποποιημένο γάλα [undo]
  • Preparation of liquid cultures [undo]
  • Learn about cognitive decline and aging [undo]
  • Αντιβιοτικά - Φουροσεμίδη [undo]
  • Metabolismo y Enzimas [undo]
  • Γονότυπος [undo]
  • Dobutamine (beta agonist) [undo]
  • Rely on physical traits [undo]
  • Alelă [undo]
  • Sacubitril-valsartan (ARNI) [undo]
  • METABOLISM OF THE CELL ENZYMES [undo]
  • Αλληλόμορφα [undo]
  • Basic Enzyme Definitions [undo]
  • Διάλειμμα μετά από περπάτημα κατά τη διάρκεια καύσωνα [undo]
  • Glipizide [undo]

Map: Michael Green_GEMD_2 (1116)
Node: 21113
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway